Results 171 to 180 of about 101,889 (202)
Some of the next articles are maybe not open access.
Budesonide for induction of remission in Crohn's disease
1996Corticosteroids continue to play a central role in induction of remission in active Crohn's disease. However, their use comes at a price of significant adverse effects when used repeatedly or for extended periods. Newer corticosteroid agents with limited systemic bioavailability offer a tantalizing option, if they can be shown to be efficacious and ...
A, Otley, A H, Steinhart
openaire +2 more sources
Induction of remission in rheumatoid arthritis: criteria and opportunities
Rheumatology International, 2008The concept of remission in rheumatology is complicated by the lack of a single gold standard measurement, spontaneous remissions and the usage of several sets of remission criteria. Feasibility is reduced by traditional clinical practice, which does not include remission criteria monitoring.
VALESINI, Guido +3 more
openaire +3 more sources
Aminosalicylates for induction of remission or response in Crohn's disease
2010Controlled clinical trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on the efficacy of sulfasalazine and mesalamine for inducing remission or clinical response in ...
Wee-Chian, Lim, Stephen, Hanauer
openaire +2 more sources
Vedolizumab for induction and maintenance of remission in ulcerative colitis
Cochrane Database of Systematic Reviews, 2014Cellular adhesion molecules play an important role in the pathogenesis of ulcerative colitis, making selective blockade of these molecules a promising therapeutic strategy. Vedolizumab, a recombinant humanized IgG1 monoclonal antibody, inhibits adhesion and migration of leukocytes into the gastrointestinal tract by binding the alpha4beta7 integrin ...
Stephen J, Bickston +6 more
openaire +2 more sources
Transdermal nicotine for induction of remission in ulcerative colitis
Cochrane Database of Systematic Reviews, 2004Ulcerative colitis is largely a disease of nonsmokers. Intermittent smokers often experience improvement in their symptoms while smoking. Nonsmokers with ulcerative colitis who begin smoking may go into remission. Randomized controlled trials were developed to test the efficacy of transdermal nicotine for the induction of remission in ulcerative ...
J, McGrath +2 more
openaire +2 more sources
Methotrexate for induction of remission in refractory Crohn's disease
2012Although corticosteroids are effective for induction of remission of Crohn's disease, many patients relapse when steroids are withdrawn or become steroid dependent. Furthermore, corticosteroids exhibit significant adverse effects. The success of methotrexate as a treatment for rheumatoid arthritis led to its evaluation in patients with refractory Crohn'
John W D, McDonald +3 more
openaire +2 more sources
Methotrexate for induction of remission in refractory Crohn's disease
2002Although corticosteroids are effective for induction of remission of Crohn's disease, approximately 20% of patients who respond relapse when steroids are withdrawn and become steroid dependent (Binder 1985). Furthermore, corticosteroids exhibit significant adverse effects.
A A, Alfadhli +2 more
openaire +3 more sources
Induction of remission in ulcerative colitis
2000Therapy for acute ulcerative colitis begins with an assessment of disease extent, severity and the response to prior treatments.
openaire +1 more source
HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIA
Lancet, The, 1977Robertpeter Gale, M J Cline
exaly